Cargando…

Intravenous immunoglobulins for the treatment of the hyper-inflammatory response in COVID-19. Another failure of immunomodulatory therapy?

Detalles Bibliográficos
Autores principales:	López-Medrano, Francisco, Aguado, José María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310784/ https://www.ncbi.nlm.nih.gov/pubmed/34325068 http://dx.doi.org/10.1016/j.cmi.2021.07.012

Ejemplares similares

The original sins of clinical trials with intravenous immunoglobulins in sepsis
por: Almansa, Raquel, et al.
Publicado: (2015)

Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab
por: Balasubramanian, S., et al.
Publicado: (2020)

Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation
por: Mimura, Yusuke, et al.
Publicado: (2022)

Immunoglobulin heavy variable somatic hyper mutation status in chronic lymphocytic leukaemia: on the threshold of a new era?
por: Langerak, Anton W., et al.
Publicado: (2020)

Erratum: Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation
Publicado: (2022)

Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia
por: Colado, Ana, et al.
Publicado: (2021)

Give or take? Intravenous immunoglobulin or plasma exchange for Guillain-Barré syndrome
por: Hughes, Richard AC
Publicado: (2011)

Commentary: Extremely early failure of transcatheter aortic valves—Another warning!
por: Antunes, Manuel J.
Publicado: (2020)

Gender Differences Associated with Hyper-Inflammatory Conditions in COVID-19 Patients
por: Shoeb, Fouzia, et al.
Publicado: (2023)

Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19)
por: Galeotti, Caroline, et al.
Publicado: (2020)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

Another piece in the puzzle
por: Maxey, Thomas S, et al.
Publicado: (2005)

Not just another genome
por: Tautz, Diethard
Publicado: (2011)

Editorial Commentary: Step on the GAS: Are We Almost There for Clindamycin and Intravenous Immunoglobulin?
por: Tan, Lionel K. K., et al.
Publicado: (2014)

Commentary: Nanobubbles—A promising technology or another therapy stuck in the laboratory?
por: Robinson, N. Bryce, et al.
Publicado: (2020)

Update on the hyper immunoglobulin M syndromes
por: Davies, E Graham, et al.
Publicado: (2010)

Immunoglobulin Infusion as Therapy Against Influenza?
por: Huckriede, Anke
Publicado: (2017)

AAV vector production: Troublesome host innate responses in another setting
por: Wright, J. Fraser
Publicado: (2023)

Another nail in the hammer's coffin?
por: Singer, Mervyn, et al.
Publicado: (2011)

Pre-hypertension: another ‘pseudodisease’?
por: Meier, Pascal, et al.
Publicado: (2013)

Another one bites the dust…
por: Houghton, Frank
Publicado: (2017)

Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, Krista, et al.
Publicado: (2021)

Systemic treatments for psoriasis: not another network meta‐analysis!
por: Leonardi‐Bee, Jo, et al.
Publicado: (2022)

In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
por: Petrone, Linda, et al.
Publicado: (2021)

Another Really, Really Big Virus
por: Van Etten, James L.
Publicado: (2011)

Another debriefing course! Who benefits?
por: Krogh, Kristian, et al.
Publicado: (2018)

Cardiac Xenotransplantation: Another Historic First?
por: Braunwald, Eugene
Publicado: (2022)

Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy
por: Castle, Dan, et al.
Publicado: (2019)

Pemphigoid gestationis and intravenous immunoglobulin therapy()
por: Yang, Anes, et al.
Publicado: (2018)

Yet another Ersatz World: The ICER Final Evidence Report for Additive Cardiovascular Therapies
por: Langley, Paul C
Publicado: (2019)

Hyper Immunoglobulin E Response in Mice with Monoclonal Populations of B and T Lymphocytes (〉 )
por: de Lafaille, Maria A. Curotto, et al.
Publicado: (2001)

Inhaled nitric oxide: another weapon in our armamentarium in the battle against acute hypoxic respiratory failure in preterm infants
por: Da-Silva, Shonola S, et al.
Publicado: (2004)

Percutaneous treatment of valvular heart disease: Die another day
por: de Winter, R. J.
Publicado: (2017)

Immunomodulatory Therapies for COVID-19 in Solid Organ Transplant Recipients
por: Fernández-Ruiz, Mario, et al.
Publicado: (2020)

Risk Factors for Failure of Initial Intravenous Immunoglobulin Treatment in Kawasaki Disease
por: Cha, Sungho, et al.
Publicado: (2008)

Dopexamine: immunomodulatory, hemodynamic, or both?
por: Hollenberg, Steven M
Publicado: (2013)

Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy
por: Adrichem, Max E., et al.
Publicado: (2022)

Commentary: Another iteration of cell-based therapy for acute ischemia-reperfusion injury, this time in the spine
por: Herrmann, Jeremy L.
Publicado: (2021)

Whole blood thromboelastometry: another Knight at the Roundtable?
por: Bluth, Martin H, et al.
Publicado: (2011)

Another brick in the wall of needs for invasive ventilation?
por: Quintel, Michael, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mu9lrjmb2qi6m792nkdo80a4lg